Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
1999 R43 PAR-98-066 XANTHOPOULOS, KLEANTHIS G AURORA BIOSCIENCES CORPORATION ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS Complete
2001 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2004 R43 PAR-01-105 HEILIG, JOSEPH S SOMALOGIC, INC. APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT Complete
2007 R33 RFA-CA-07-016 MACBEATH, GAVIN HARVARD UNIVERSITY QUANTITATIVE INTERACTION NETWORKS FOR TYROSINE-PHOSPHORYLATED PROTEINS Complete
2010 R21 RFA-CA-09-008 MITRA, ROBI D WASHINGTON UNIVERSITY HIGHLY PARALLEL EDMAN SEQUENCING OF INDIVIDUAL PEPTIDE MOLECULES Complete
2014 R33 RFA-CA-13-002 LOEB, LAWRENCE A UNIVERSITY OF WASHINGTON VALIDATION AND ADVANCED DEVELOPMENT OF DUPLEX SEQUENCING Complete
2017 R33 RFA-CA-16-002 SINGH, ANKUR CORNELL UNIVERSITY LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics Complete
2017 R33 RFA-CA-16-002 YATES, JOHN R SCRIPPS RESEARCH INSTITUTE Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry Complete
2001 R33 PAR-98-067 WIND, ROBERT A BATTELLE PACIFIC NORTHWEST LABORATORIES INTEGRATED OPTICAL/MAGNETIC RESONANCE MICROSCOPY Complete
2003 R43 PAR-01-105 DIATCHENKO, LUDA ATTAGENE, INC. PROFILING OF SIGNAL TRANSDUCTION PATHWAYS IN CANCER Complete
2007 R21 RFA-CA-07-002 XU, XIAOWEI UNIVERSITY OF PENNSYLVANIA ULTRASENSITIVE FACTT ASSAYS FOR SERUM BIOMARKERS Complete
2009 R43 RFA-CA-08-011 ZWICK, MICHAEL G ANDROBIOSYS, INC. PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU Complete
2013 R33 RFA-CA-12-003 TACKETT, ALAN JACKSON UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT OF MASSSQUIRM TO QUANTITATIVELY MEASURE LYSINE METHYLATION Complete
2016 R33 RFA-CA-15-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS GESI: a novel technology for functional imaging in living cells Complete
2000 R43 PAR-98-066 BOGEN, STEVEN A CYTOLOGIX CORPORATION INSTRUMENTATION FOR IN SITU ANALYSIS TUMORS Complete
2002 R43 PAR-01-105 YANG, XING GENEOHM SCIENCES, INC. MULTIPLEXED DNA-MEDIATED ELECTOCHEMICAL SENSORS Complete
2006 R21 RFA-CA-06-003 HAAB, BRIAN B. VAN ANDEL RESEARCH INSTITUTE DEFINING SECRETED GLYCAN ALTERATIONS IN PANCREATIC CANCER Complete
2009 R21 RFA-CA-08-006 MANALIS, SCOTT R MASSACHUSETTS INSTITUTE OF TECHNOLOGY DEVELOPING A SINGLE CELL GROWTH MONITOR FOR CLASSIFYING THERAPEUTIC RESPONSE Complete
2012 R33 RFA-CA-12-003 ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE ACTIVATABLE ONE-DROP AND ONE-STEP ASSAY FOR CIRCULATING TUMOR CE Complete
2016 R21 RFA-CA-15-002 HELD, JASON M. WASHINGTON UNIVERSITY DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER Complete
2000 R21 PAR-99-100 WANG, BINGHE NORTH CAROLINA STATE UNIVERSITY RALEIGH FLUORESCENT TAGS TARGETED ON CELL SURFACE CARBOHYDRATES Complete
2002 R33 PAR-01-104 WAGGONER, ALAN S CARNEGIE-MELLON UNIVERSITY NEAR IR FLUORESCENT PROBES/MOLECULAR ANALYSIS OF CANCER Complete
2005 R21 RFA-CA-05-004 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED CELL PREPARATION IN TUBES FOR 3D MICROSCOPY Complete
2008 R21 RFA-CA-07-035 EDWARDS, JEREMY S. UNIVERSITY OF NEW MEXICO SEQUENCING CHR. 6 IN MELANOMA PATIENTS Complete
2011 R21 RFA-CA-10-005 LAVIE, ARNON UNIVERSITY OF ILLINOIS AT CHICAGO ENZYME-DELIVERY SCAFFOLD TECHNOLOGY FOR TARGETED CANCER KILLING. Complete
2015 R21 RFA-CA-14-005 GERTZ, JASON UNIVERSITY OF UTAH DEVELOPMENT OF ENHANCER RNA-BASED BIOMARKERS IN FFPE TISSUE Complete
1999 R43 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. GENE EXPRESSION ANALYSIS ON RANDOMLY ORDERED DNA ARRAYS Complete
2001 R44 PAR-99-101 CHEE, MARK S. ILLUMINA, INC. RANDOM ARRAYS FOR GENE EXPRESSION PROFILING Complete
2004 R44 PAR-01-106 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC CLINICAL STUDIES OF CIRCULATING EPITHELIAL CANCER CELLS Complete
2007 R41 RFA-CA-07-011 CAO, HAN BIONANOMATRIX, INC. CONTINUOUS CHROMOSOME SORTING WITH MICRO/NANOFLUIDICS Complete
2010 R21 RFA-CA-09-008 LEE, CHENG S UNIV OF MARYLAND, COLLEGE PARK CITP-BASED SELECTIVE TISSUE PROTEOME ENRICHMENT Complete
2014 R33 RFA-CA-13-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA MULTIPLEXED KINASE BIOSENSOR TECHNOLOGY TO DETECT LEUKEMIA SIGNALING WITH MASS SP Complete
2020 R33 RFA-CA-19-020 HIGGINSON, DANIEL SLOAN-KETTERING INST CAN RESEARCH Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways Active
2019 R33 RFA-CA-18-003 SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation Active
2018 R21 RFA-CA-17-012 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing Active
2020 R21 RFA-CA-19-019 LI, WEI TEXAS TECH UNIVERSITY Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip Active
2019 R33 RFA-CA-18-003 FIOLKA, RETO PAUL UT SOUTHWESTERN MEDICAL CENTER Multiscale microscope for 3D cancer imaging in model organisms and organoids Active
2020 R21 RFA-CA-19-019 LIANG, FU-SEN CASE WESTERN RESERVE UNIVERSITY Spatiotemporal Epitranscriptome Editing Technology Active
2019 R33 RFA-CA-18-003 DE VLAMINCK, IWIJN CORNELL UNIVERSITY Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer Active
2020 R44 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues Active
2019 R33 RFA-CA-18-003 YANG, JENNY J. GEORGIA STATE UNIVERSITY Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment Active
2018 R33 RFA-CA-17-013 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity Active
2020 R43 PAR-18-303 REDER, NICHOLAS LIGHTSPEED MICROSCOPY, INC. Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies Active
2019 R33 RFA-CA-18-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia Active
2020 R21 RFA-CA-19-019 SHVETS, GENNADY CORNELL UNIVERSITY Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces Active
2019 R33 RFA-CA-18-003 BREUNIG, JOSHUA JOHN CEDARS-SINAI MEDICAL CENTER GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models Active
2018 R43 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues Active
2020 R21 RFA-CA-19-019 TEWARI, MUNEESH UNIVERSITY OF MICHIGAN AT ANN ARBOR Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers Active
2019 R33 RFA-CA-18-003 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES Optimization and validation of integrated microscale technologies for low-cost; automated production of PET molecular imaging tracers for cancer research Active
2020 R33 RFA-CA-19-020 WANG, SIYUAN YALE UNIVERSITY Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer Active

Pages